Healthtech SaaS startup Doceree has secured $35 million in a Series-B funding round led by Creaegis.
According to the statement, the round also included contributions from current investors Eight Roads Ventures and F-Prime Capital. The money will help Doceree expand its team, scale worldwide growth, and accelerate the development of products, it was added.
“The pharma messaging space is evolving at a fast pace and our solutions are aligned to meet the immediate requirements of the life sciences industry. The investment speaks volumes about the value we are creating in the space,” Harshit Jain, founder and global CEO, Doceree, said.
Doceree is a worldwide network of programmatic marketing platforms that are accessible to physicians only.
“Our past experience of investing in pioneering global SaaS companies and in the healthcare ecosystem will enable us to support the company’s mission to create superior outcomes for pharma brands, providers and patients,” Prakash Parthasarathy, managing partner and CIO and Nitish Bandi, partner, Creaegis, said jointly.
Doceree’s proprietary ESPYIANTM technology identifies and precisely targets Healthcare Professionals for a truly individualised online experience.